trending Market Intelligence /marketintelligence/en/news-insights/trending/syrj8giks1oxfvnswb8x-q2 content esgSubNav
In This List

T2 Biosystems plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


T2 Biosystems plans common stock offering

T2 Biosystems Inc. plans to sell 5,650,000 common shares as part of an underwritten registered public offering.

The Lexington, Mass.-based diagnostic company also plans to grant its underwriters an option to buy up to an additional 847,500 shares.

Leerink Partners LLC is acting as joint book-running manager for the offering. Canaccord Genuity LLC is acting as passive book-running manager. Janney Montgomery Scott LLC, JonesTrading Services LLC and WBB Securities LLC are acting as co-managers for the offering.